We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+48.85%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$634M
AUM Growth
+$33.5M
(+5.6%)
Cap. Flow
-$90.2M
Cap. Flow
% of AUM
-14.22%
Top 10 Holdings %
Top 10 Hldgs %
8.15%
Holding
413
New
130
Increased
19
Reduced
118
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LivePerson
LPSN
|
+$4.19M |
| 2 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
+$4.14M |
| 3 |
TBCH
Turtle Beach Corp
TBCH
|
+$4.13M |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$4.07M |
| 5 |
Tactile Systems Technology
TCMD
|
+$4.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$6.81M |
| 2 |
CUTR
Cutera, Inc.
CUTR
|
+$4.92M |
| 3 |
Vericel Corp
VCEL
|
+$4.77M |
| 4 |
ESPR
Esperion Therapeutics
ESPR
|
+$4.75M |
| 5 |
INST
Instructure, Inc.
INST
|
+$4.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.66% |
| 2 | Technology | 24.9% |
| 3 | Consumer Discretionary | 14.4% |
| 4 | Industrials | 10.81% |
| 5 | Financials | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGTI
26
DELISTED
PGT, Inc.
PGTI
| $4.16M | 0.66% |
199,686
-21,195
| -10% | -$414K |
|
27
Cavco Industries
CVCO
$4.36B
| $4.13M | 0.65% |
+19,877
| New | +$3.74M |
|
28
ICF International
ICFI
$1.5B
| $4.08M | 0.64% |
+57,464
| New | +$3.9M |
|
29
BJ's Restaurants
BJRI
$1.47B
| $4.07M | 0.64% |
+67,904
| New | +$3.64M |
|
30
Fair Isaac
FICO
$31.8B
| $4.04M | 0.64% |
20,893
-2,099
| -9% | -$380K |
|
31
OneSpan
OSPN
$584M
| $4M | 0.63% |
+203,714
| New | +$3.67M |
|
32
STAAR Surgical
STAA
$1.19B
| $3.99M | 0.63% |
+128,820
| New | +$3.01M |
|
33
Varonis Systems
VRNS
$4.67B
| $3.98M | 0.63% |
160,458
-74,808
| -32% | -$1.79M |
|
34
FIVE9
FIVN
$2.08B
| $3.88M | 0.61% |
112,287
-19,451
| -15% | -$630K |
|
35
Natera
NTRA
$36.4B
| $3.87M | 0.61% |
+205,543
| New | +$2.5M |
|
36
Axogen
AXGN
$2.2B
| $3.81M | 0.6% |
75,926
-44,127
| -37% | -$1.94M |
|
37
Chegg
CHGG
$116M
| $3.73M | 0.59% |
134,404
-67,908
| -34% | -$1.71M |
|
38
PJT Partners
PJT
$4.26B
| $3.73M | 0.59% |
+69,926
| New | +$3.83M |
|
39
Trade Desk
TTD
$8.97B
| $3.72M | 0.59% |
+396,640
| New | +$2.79M |
|
40
Heron Therapeutics
HRTX
$93.4M
| $3.71M | 0.59% |
95,531
-84,380
| -47% | -$2.69M |
|
41
Korn Ferry
KFY
$4.31B
| $3.71M | 0.58% |
59,880
-6,024
| -9% | -$338K |
|
42
Inspire Medical Systems
INSP
$1.47B
| $3.66M | 0.58% |
+102,656
| New | +$3.31M |
|
43
Freshpet
FRPT
$3.04B
| $3.6M | 0.57% |
+131,211
| New | +$2.8M |
|
44
Encompass Health
EHC
$11.3B
| $3.53M | 0.56% |
65,555
-25,741
| -28% | -$1.29M |
|
|
GHDX
45
DELISTED
Genomic Health, Inc.
GHDX
| $3.53M | 0.56% |
+69,993
| New | +$2.78M |
|
46
Viking Therapeutics
VKTX
$3.88B
| $3.5M | 0.55% |
369,082
+54,081
| +17% | +$360K |
|
|
AMED
47
DELISTED
Amedisys
AMED
| $3.5M | 0.55% |
+40,912
| New | +$3M |
|
|
IMMU
48
DELISTED
Immunomedics Inc
IMMU
| $3.49M | 0.55% |
147,400
+97,120
| +193% | +$1.95M |
|
49
Madison Square Garden
MSGS
$9.59B
| $3.46M | 0.55% |
+15,646
| New | +$2.89M |
|
50
Iridium Communications
IRDM
$4.7B
| $3.45M | 0.54% |
+214,328
| New | +$2.92M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2018 Portfolio in Review
As of Q2 2018, EAM Investors held 413 positions worth $634M, up 5.6% from $601M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
EAM Investors withdrew a net $90.2M in Q2 2018, closing 127 positions and reducing 118 holdings. Its most notable exit was Nektar Therapeutics, an estimated $6.81M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, EAM Investors opened a new position in LivePerson worth $4.69M.
- EAM Investors's largest Q2 2018 buy was LivePerson: 14,807 shares worth $4.69M.
- EAM Investors added most to Malibu Boats in Q2 2018, an estimated $3.06M increase.
- EAM Investors's biggest Q2 2018 reduction was Vericel Corp, cutting an estimated $4.77M.
- EAM Investors fully exited Nektar Therapeutics in Q2 2018, selling an estimated $6.81M.
- EAM Investors's ten largest holdings make up 8.1% of its $634M portfolio in Q2 2018.
- EAM Investors opened 130 new positions and closed 127 in Q2 2018.
- EAM Investors's portfolio value rose 5.6% quarter-over-quarter to $634M.
Based on EAM Investors's 13F filing for Q2 2018, filed 3 Aug 2018.